Wisconsin Senate Bill SB42

Wisconsin 2025-2026 Regular Session

• Introduced: 2/12/25
• Refer: 2/12/25
• Report Pass: 3/14/25

Caption

Permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)

Impact

The legislation is poised to enhance access to contraceptive methods by enabling pharmacists to serve as direct providers, which could be especially beneficial in areas with limited access to traditional healthcare providers. By authorizing pharmacists to dispense hormonal contraceptives, the bill could potentially reduce barriers for patients needing immediate access to these medications. Additionally, it places an emphasis on reinforcing the importance of regular health consultations between patients and licensed medical professionals.

Summary

Senate Bill 42 seeks to empower pharmacists in Wisconsin by allowing them to prescribe hormonal contraceptive patches and self-administered oral contraceptives. This bill necessitates the establishment of rules by the Pharmacy Examining Board, which must consult with various healthcare boards before implementing these rules. Importantly, the bill stipulates that pharmacists must use a self-assessment questionnaire prior to prescribing contraceptives, ensuring patients acknowledge that these methods do not provide protection against sexually transmitted diseases. Furthermore, patients must undergo a blood pressure screening to ensure safe use of these contraceptives.

Conclusion

Overall, SB42 reflects an evolving approach to healthcare delivery in the state, aiming to leverage the existing pharmacy infrastructure to improve women’s health and contraceptive access. Its successful implementation will rest on the establishment of robust guidelines and training provisions to ensure the safety and efficacy of contraceptive dispensing by pharmacists.

Contention

Despite its potential benefits, SB42 raises several points of contention. Opponents may voice concerns regarding the adequacy of pharmacist training in prescribing these medications and the implications for patient safety. There could be discussions surrounding the adequacy of assessments performed by pharmacists versus traditional healthcare providers. Furthermore, some may question whether empowering pharmacists in this capacity effectively addresses broader systemic issues in healthcare access and education on sexual health.